| Home | Abstracts List |
Library |
| Previous List | Jumex ® (selegiline) |
Next List |
| For viewing the abstract double click on the title below: | ||
| 1)
Selegiline as the primary treatment
of Parkinson's disease--a long-term double-blind study. 2) Clinical pharmacokinetics and pharmacodynamics of selegiline. An update. 3) Selegiline in de novo parkinsonian patients: the Finnish study. 4) Symptomatic effect of selegiline in de novo Parkinsonian patients. The French Selegiline Multicenter Trial. 5)Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease. 6) Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis.
|
||